Estrogen (ER) and progesterone receptors (PgR) were evaluated in samples from primary tumors in 539 patients with stage I1 breast cancer participating in a randomized multicenter controlled clinical trial on adjuvant therapy. At the cut-off points of 10 fmol EWmg protein and 30 fmol PgR/ mg protein,
Genetic evolution of breast cancer: II. relationship with estrogen and progesterone receptor expression
β Scribed by H. Magdelenat; M. Gerbault-Seureau; C. Laine-Bidron; M. Prieur; B. Dutrillaux
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 715 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In some tumors, defects in mismatch repair enzymes lead to errors in the replication of simple nucleotide repeat segments RER+ tumors. This condition is commonly known as microsatellite instability (MSI) because of the frequent mutations of microsatellite sequences. Although the MSI phenotype is wel
The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis